Search research articles
Contact Us
Filters
Showing results (41-50 of 205) with videos related to
Page
of 21
Sort By:
Frontiers in Immunology
|
June 6, 2018
Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice
Dina Al Dulaimi, Jihene Klibi, Veronica Olivo Pimentel, et al.
Melanoma Research
|
March 6, 2013
Ipilimumab-induced acute severe colitis treated by infliximab
Cecile Pagès, Jean M Gornet, Gentiane Monsel, et al.
Alimentary Pharmacology & Therapeutics
|
April 29, 2020
Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids
Robert Salameh, Julien Kirchgesner, Matthieu Allez, et al.
Case Reports in Gastroenterology
|
April 22, 2014
Cephalic duodenopancreatectomy for hyperalgic duodenal Crohn's disease fistulized in the pancreatic gland
Sabra Guellouz, Benjamin Pariente, Claire Benet, et al.
Gastroenterologie Clinique Et Biologique
|
March 1, 2006
[Exclusive ileal endometriosis]
Natacha Roger, Nicolas Munoz-Bongrand, Alain Vila, et al.
Clinical Pharmacokinetics
|
December 18, 2014
Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease
David Ternant, Zahir Berkane, Laurence Picon, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|
September 6, 2014
Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's disease
Justine Bellinger, Nicolas Munoz-Bongrand, Benjamin Pariente, et al.
Journal of the American Academy of Dermatology
|
January 24, 2007
Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients
Laurence Fardet, Alain Dupuy, Delphine Kerob, et al.
Alimentary Pharmacology & Therapeutics
|
April 7, 2020
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
Hadrien Alric, Aurélien Amiot, Julien Kirchgesner, et al.
Frontiers in Medicine
|
June 20, 2022
A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
Signe Hässler, Sophie Camilleri-Broët, Matthieu Allez, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 205) with videos related to
Sort By:
Page
of 21
Frontiers in Immunology
|
June 6, 2018
Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice
Dina Al Dulaimi, Jihene Klibi, Veronica Olivo Pimentel, et al.
Melanoma Research
|
March 6, 2013
Ipilimumab-induced acute severe colitis treated by infliximab
Cecile Pagès, Jean M Gornet, Gentiane Monsel, et al.
Alimentary Pharmacology & Therapeutics
|
April 29, 2020
Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids
Robert Salameh, Julien Kirchgesner, Matthieu Allez, et al.
Case Reports in Gastroenterology
|
April 22, 2014
Cephalic duodenopancreatectomy for hyperalgic duodenal Crohn's disease fistulized in the pancreatic gland
Sabra Guellouz, Benjamin Pariente, Claire Benet, et al.
Gastroenterologie Clinique Et Biologique
|
March 1, 2006
[Exclusive ileal endometriosis]
Natacha Roger, Nicolas Munoz-Bongrand, Alain Vila, et al.
Clinical Pharmacokinetics
|
December 18, 2014
Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease
David Ternant, Zahir Berkane, Laurence Picon, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|
September 6, 2014
Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's disease
Justine Bellinger, Nicolas Munoz-Bongrand, Benjamin Pariente, et al.
Journal of the American Academy of Dermatology
|
January 24, 2007
Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients
Laurence Fardet, Alain Dupuy, Delphine Kerob, et al.
Alimentary Pharmacology & Therapeutics
|
April 7, 2020
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
Hadrien Alric, Aurélien Amiot, Julien Kirchgesner, et al.
Frontiers in Medicine
|
June 20, 2022
A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
Signe Hässler, Sophie Camilleri-Broët, Matthieu Allez, et al.
Page
of 21